Ledger.Open graph →
SEC Form D · filed May 8, 2020

Atsena Therapeutics, Inc

Offering
$8.1M
Sold
$4.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Shannon Boye · Durham, NCExec · DirectorSanford Boye · Durham, NCExecBenjamin Yerxa · Durham, NCDirectorDaniel W. Landry · El Segundo, CAExecAnkur W. Desai · El Segundo, CAExec · DirectorHirsh B. Hirsh · Blacklick, OHDirectorRichard W. Libretti · Morristown, NJExec · DirectorKeith W. Archer · Foster City, CADirectorEmily W. Fairbairn · Foster City, CADirectorJohn Zeratsky · Milwaukee, WIExec · DirectorMichael Dial · Durham, NCDirectorEli Blee-Goldman · Milwaukee, WIDirectorPatrick Ritschel · Durham, NCExec · DirectorHoward Hall · Boston, MAExec · DirectorHemant Y. Taneja · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗